The U.S. Food and Drug Administration (FDA) has authorized COVID-19 vaccines for the fall — but only for high-risk groups.
Health and Human Services Secretary Robert F. Kennedy announced the FDA’s most recent actions on Wednesday in a post on X.
“I promised 4 things,” Kennedy wrote. “1. to end covid vaccine mandates; 2. to keep vaccines available to people who want them, especially the vulnerable; 3. to demand placebo-controlled trials from companies; 4. to end the emergency.”
“In a series of FDA actions today we accomplished all four goals.”
In the post, RFK stated that the FDA has issued “marketing authorization” for high-risk groups for the following vaccines: Moderna (6 months and older), Pfizer (5 years and older) and Novavax (12 and up).
“These vaccines are available for all patients who choose them after consulting with their doctors,” RFK wrote.
High-risk groups include older adults over 65 and those who are more likely to develop severe COVID illness.
On its website, the CDC lists conditions that may increase the risk of severe COVID, including asthma, cancer, heart conditions, cerebrovascular disease, diabetes, dementia, mood disorders, obesity, Parkinson’s, and chronic disease of the lungs, liver or kidneys, among many others.
RFK also announced that the emergency use authorizations for COVID vaccines have been rescinded.
High-risk groups include older adults over 65 and those who are more likely to develop severe COVID illness. (iStock)
“The American people demanded science, safety, and common sense,” RFK went on. “This framework delivers all three.”
Before this change, the Centers for Disease Control and Prevention had recommended the vaccine for all Americans 6 months and older.
In May 2025, Kennedy announced that COVID-19 vaccines would be removed from the CDC’s routine immunization schedule for healthy children and pregnant women.
Instead of a universal recommendation, the CDC’s updated guidance calls for “shared clinical decision-making,” in which parents and doctors discuss the benefits and risks of vaccination for each individual case.
Before this change, the Centers for Disease Control and Prevention had recommended the vaccine for all Americans 6 months and older.(iStock)
However, the American Academy of Pediatrics (AAP) still includes it in its annual immunization schedule, as Fox News Digital previously reported.
“It should be a conversation between the pediatrician, patient and parent, and should depend on the child’s health as well as the current state of COVID,” Dr. Marc Siegel, Fox News senior medical analyst, previously told Fox News Digital.
Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
Keeley Hazell makes shocking claims about ‘Ted Lasso’ lead female character
Keeley Hazell has revealed she came close to landing a major role in Ted Lasso, a character that was directly inspired by her.
In her new memoir, Everyone’s Seen My Tits, the actress shared that the idea was first brought up by Jason Sudeikis, with whom she was previously linked romantically.
Hazell recalled meeting with Sudeikis to talk about “the part he had written for me” while he was developing what would eventually become the Apple TV+ hit series.
At the time, the project hadn’t been picked up, but the possibility of being a lead on television thrilled her. “The idea of me being a lead in a TV show was enough to make me wet my pants with excitement,” she wrote.
According to Hazell, Sudeikis discussed creating a role named “Keeley” for the show, mirroring her own name.
She auditioned several times for the part and, as she explained, “according to J, I was at the top of the list, but casting wanted to see another scene.”
For her final round, Sudeikis read with her directly.
In the end, however, she was told she would not be cast in the role. That part went instead to Juno Temple, who went on to play Keeley Jones throughout the series’ entire run beginning in 2020.
Hazell admitted the news left her devastated. “I felt like I’d been punched in the chest,” she wrote, adding, “Once I didn’t get cast as Keeley, I decided that acting could go f— itself.”
She eventually accepted a smaller role on Ted Lasso as Bex, appearing in several episodes. While her part was brief, she still encountered reminders of the character she almost played.
Hazell recalled a moment when she gave her name while ordering food and the server responded, “Oh, Keeley, like the character from Ted Lasso!” She admitted her look of horror was mistaken for confusion before the server asked if she had seen the show.
Reflecting on the experience, Hazell pointed out how the fictional Keeley Jones often joked about being “sort of famous for being almost famous,” a line that she felt hit particularly close to home.
Alessandro Galleni has been Genoa’s chief strategy officer since November 2022. The club has a glorious past — only Milan, Inter and Juventus have won more Serie A titles — but in the present, Genoa have to work hard to keep up with bigger, better-resourced clubs. Recruitment and budgeting are crucial.
Here, Galleni shares seven truths about how the transfer window works.
No. 1: Players aren’t commodities and there really is no such thing as a ‘market rate’
Plenty of factors go into determining a transfer fee: wages, length of contract, age, position, whether a club has a need to acquire a player or has a need to offload, what the budget is, and how far along the player is in his development. Galleni says there’s a premium for upside: an exceedingly athletic player might be able to improve technically and therefore be worth the investment. (The opposite — a very technically gifted player who becomes a better athlete — is far rarer.)
“Right up until age 23 or so, some players can improve physically, becoming stronger, fitter and quicker,” says Galleni. “Some mature faster than others, you have to figure out where they are on their development pathway.”
Beyond that, he cites Mateo Retegui, a player Genoa acquired from Argentina’s Boca Juniors for €12m in 2023-24, transferred to Atalanta for €22m plus €3m in bonuses a year later and has now moved to Al-Qadsiah in Saudi Arabia for €60m, plus €7m in bonuses. It’s not as if Retegui, in the space of two seasons, has improved fivefold.
Retegui scored seven goals for Genoa — not a huge amount, but he was on a conservative side that didn’t necessarily provide the sort of service he needed. Atalanta realized he would be far more prolific in their system, which was more attacking and featured plenty of crosses. Genoa knew that Atalanta had some money to spend, so they held out for the best transfer fee they could get. Retegui went on to become the top scorer in Serie A, proved himself in the Champions League and then left for a huge transfer fee to Al-Qadsiah in the Saudi Pro League, where budgets are even higher.
In other words, the progression in the fees paid for his contract wasn’t just a function of his growth as a player, but the result of a range of other factors.
No. 2: Ideally, teams could deal with clubs directly when transferring players, but sometimes they are better off using intermediaries
Galleni says that within Italy, Genoa generally don’t use intermediaries, preferring to deal club-to-club. But the game is global and only the biggest clubs migiht have contacts or a scouting presence in every league or on every continent.
“We scout around the world, but we’re not going to know what each team needs or what players might be available from each club,” he said. “Somebody will call and suggest players to us who might be available. Or they’ll ask about our players on behalf of other clubs. Usually we deal with intermediaries who know one or two leagues well. In some markets where we’ve done a lot of business, we don’t necessarily need this. A lot depends on personal relationships: who you trust and who has the right connections in the right markets.
“If I have, say, a promising striker in my youth team who needs to go on loan to get first-team football I’m not going to know off the top of my head what clubs in, say, the Austrian top division or the French second division are looking for a forward. An intermediary will offer that service. Of course, these days, there are also online services that match clubs with players. It’s very much a global game.”
No. 3: Managers, by necessity, tend to think shorter term while clubs have to think medium and long term. You have to find a way for these goals to align
There’s also the reality that unless you’re at a very top club, your manager is unlikely to stick around for an extended period: if he does well, he’ll move to a bigger club and if he does poorly, he will be sacked. A club like Genoa aims to be competitive, but will necessarily look to bring in players they can develop and later shift at a profit to help cover their operating expenses.
The manager has to fit into that strategy, and the club emphasizes it has a profile of the sort of manager it wants. Not coincidentally he’s proud of the fact that Genoa ranked sixth among clubs in Europe’s Big Five leagues for first-team minutes played by Under 18s last season.
“We can’t afford to find talent where bigger clubs find it, or acquire established stars,” he said. “What we do is we offer players a chance to grow and a window in which to showcase their growth. And, of course, we complete the team with older professionals who set a good example, reflect our values and provide the cohesion we need.”
play
1:48
Does Alonso now believe in Rodrygo?
Gab Marcotti and Julien Laurens discuss whether they think Real Madrid manager Xabi Alonso now believes in Rodrygo as he started in their 3-0 win against Oviedo.
No. 4: Managers have to decide the profile of the player they want, and then clubs have to give them a list of alternatives that fit the profile. You can’t fall in love with a specific player, and think that only he can do the job
Most have heard the story about how Jurgen Klopp wanted to sign Julian Brandt, but the club pushed for Mohamed Salah, and the rest, as they say, is history. Coaches have to have an idea of how they want to play and the qualities the players need to have in their system, but it’s critical they understand that players are fungible: If one target is out of reach financially, you move to the next who fits the profile.
“A coach can’t start with an individual they want, it has to be with a profile and the reality is that there will be many players who fit that profile,” says Galleni. “Within that profile, there is a cluster of alternatives and you find the one that’s right for you.”
And, of course, it can’t be up to the coach to choose the players: that’s the job of the director of football (at Genoa, it’s Marco Ottolini) and the scouting department.
No. 5: Developing players and designing the right pathways for them is critical to a club’s success
Investing in players — both those from your academy and those you sign — who develop at your club will cost you less and will end up either contributing to your first team or leaving for another club (and garnering a transfer fee). It’s a big part of the reason why Genoa have invested in a newly opened youth complex (Badia di Sant’Andrea) to help attract and retain younger players. It’s not just about spotting upside, either — it’s about having a plan for how you’re going to develop that upside.
“We had a very promising defender named Honest Ahanor last season,” he said. “He was with the first team in preseason, and trained with them all year while playing mostly for the youth team. He made most of his first-team appearances in the last month of the season, but showed enough for us to transfer him to Atalanta this summer for a fee that could rise to €20 million.
“Now, we could have left him in the youth side, or we could have pushed him into the first team straight away. But we believe our plan allowed him to adapt to playing against grown men — he was 16 when he started — and grow gradually.”
“That’s an internal example, but I can also cite Sebastian Otoa, a player we signed as a 20-year-old from AaB in Denmark in January,” Galleni added. “He didn’t play a single minute until April and only made three first-team appearances. We gave him a period of adaptation, and we expect him to be ready to contribute this year.”
Finding potential upside isn’t just about youngsters. It’s also about identifying players who have struggled elsewhere — whether through injury, or other reasons — and helping them relaunch their career. That too requires a pathway.
No. 6: Data is important in recruitment, as is live scouting and learning about players on and off the pitch. You want to be data-advised rather than data-driven, but it’s essential that any newcomer fits the DNA of the club
Galleni is emphatic about this. Genoa have more than 28,000 season-ticket holders and a fan base that is hugely committed and demands commitment from its players.
“Intensity and a fighting attitude is in our club’s DNA and it’s just as important to us as talent and professionalism,” he said. “There are other clubs who maybe have less passionate fans or fewer fans or where the city is more relaxed and certain types of players are more suited to that environment. If a player is going to be rattled by our fans, if he’s going to respond negatively to criticism, this is not the right place for him. You feel the pressure here the moment you step on the pitch and some young players, however talented they may be, might not be ready for it.
“One of the best examples is one of our captains, Johan Vazquez, who has also captained Mexico. He’s a leader and a warrior on the pitch, and he fit us perfectly from the moment he arrived.”
No. 7: You can look for players in traditional ‘hotbeds’ — areas that have produced many successful players — but that means greater competition. You can also look for players in other markets, where fewer competitors are looking, but you have to get the balance right
“We’ve found that the Nordic markets, especially Danish and Norwegian, fit our DNA,” Galleni says. “And, of course, the more we operate in those markets the more we get to know them and the more they get to know us.”
From Morten Frendrup to Mikael Ellertsson to Morten Thorsby, Genoa appear to have a pipeline to Scandinavia, and it works for them. You have to stay open-minded, but there’s nothing wrong with going back to what you know.
Pfizer’s Covid vaccine Comirnaty, seen at a CVS Pharmacy in Eagle Rock, California, Sept. 14, 2023.
Irfan Khan | Los Angeles Times | Getty Images
The Food and Drug Administration on Wednesday approved the latest round of Covid vaccines in the U.S., but set new limits on who can get them.
The agency ended its broader authorization of the shots, only clearing them for people at higher risk of severe illness. That includes those 65 and up and younger adults with at least one underlying condition that puts them at higher risk.
The move could complicate access to the shots for millions of Americans, and raises questions about whether insurance plans will still cover them for healthy adults.
“The emergency use authorizations for Covid vaccines, once used to justify broad mandates on the general public during the Biden administration, are now rescinded,” Health and Human Services Secretary Robert F. Kennedy Jr. said in a post on X.
“The American people demanded science, safety, and common sense,” he said. “This framework delivers all three.”
More CNBC health coverage
It follows several efforts by Kennedy, a prominent vaccine skeptic, to change immunizations in the U.S. The new limited authorizations are a break from U.S. vaccine policy in previous years, which recommended an annual Covid shot for all Americans 6 months and up.
A key panel of vaccine advisors to the Centers for Disease Control and Prevention must vote to recommend the Covid shots. But Kennedy earlier this year gutted that panel and named new members, some of whom are widely known vaccine critics.
In the post, Kennedy said the shots are available for all patients who choose them after consulting with their doctors. But it’s unclear how easily patients without high-risk factors will be able to get a Covid vaccine.
Kennedy said the FDA has authorized Moderna‘s shot for those 6 months and up, Pfizer‘s vaccine for people ages 5 and up, and Novavax‘s jab for those ages 12 and up, but only for those specifically at higher risk of getting severely sick from the virus.
Adults ages 65 and up are at higher risk of severe Covid, and so are younger adults who are immunocompromised or have underlying medical conditions such as cancer, obesity, diabetes, chronic kidney disease and heart diseases, according to the CDC‘s website.
The end of the so-called emergency use authorizations means that Pfizer’s shot is no longer cleared for children ages 6 months to 4 years. It comes after Pfizer in August said it has requested that the FDA keep that authorization in place for the upcoming fall and winter season.
In a release, Pfizer confirmed that the FDA had cleared its updated Covid shot for use in adults 65 and above and those ages five through 64 with at least one underlying condition that puts them at high risk for severe illness. The company will begin shipping the shot immediately, and it will be available in pharmacies, hospitals and clinics nationwide “in the coming days.”
In a separate release, Moderna also confirmed that its updated Covid shot is approved for those 65 and up and people 6 months through 64 years of age who are at higher risk of severe illness. The company added that its new, next-generation Covid vaccine is approved for older adults and high-risk patients ages 12 through 64. Moderna said it expects the shots to be available in the coming days.
Shares of Pfizer and Moderna were trading slightly higher Wednesday afternoon, while Novavax shares dipped.
In May, the CDC dropped the recommendation that pregnant women and healthy children receive Covid shots. But the American Academy of Pediatrics diverged from the agency earlier this month, recommending Covid shots for children between 6 months and 2 years old.
In a statement on Wednesday, Dr. Susan Kressly, president of the American Academy of Pediatrics, called the FDA’s more limited approval “deeply troubling.” She said respiratory illnesses like Covid can be “especially risky for infants and toddlers, whose airways and lungs are small and still developing.”
“Any parent who wants their child vaccinated should have access to this vaccine,” she said. “Today’s unprecedented action from HHS not only prevents this option for many families, but adds further confusion and stress for parents trying to make the best choices for their children.”
She said the AAP urges the administration to “allow these choices to remain with medical experts and families.”
The American College of Obstetricians and Gynecologists also advised pregnant women to get the Covid vaccine to protect themselves and their infants, who cannot be immunized until they are 6 months old.
YouTube TV subscribers could be set to lose access to content from media company Fox, including college football, unless the sides strike a new carriage deal.
With the current agreement between the sides nearing a renewal deadline, YouTube TV could pull Fox sports, business and news channels from its platform by 5 p.m. EST on Wednesday.
In a blog post, Google-owned YouTube said Fox was “asking for payments that are far higher than what partners with comparable content offerings receive.” The company added that it hoped to reach a deal that’s “fair for both sides” without “passing on additional costs to our subscribers.”
If Fox content becomes unavailable on YouTube TV “for an extended period of time,” YouTube also noted it would provide members with a $10 credit. YouTube TV’s base plan, which currently boasts access to over 100 live channels, costs $82.99 a month.
A spokesperson for Google did not have any additional comments when reached Wednesday by The Associated Press.
Fox said Wednesday that it was “disappointed that Google continually exploits its outsized influence by proposing terms that are out of step with the marketplace.” The broadcast giant added that it remained committed to reaching an agreement, but was alerting viewers that they could potentially lose access to Fox programming on YouTube TV “unless Google engages in a meaningful way soon.”
Fox directed subscribers to keepfox.com — a site noting that, in addition to Fox Sports, Business and News, YouTube TV may no longer carry FS1 and the Big Ten Network, which is majority-owned by Fox, if a deal isn’t reached.
Federal Communications Commission Chairman Brendan Carr has also chimed in on the dispute, urging Google to “get a deal done” in a social media post on Tuesday.
“Google removing Fox channels from YouTube TV would be a terrible outcome,” Carr wrote on X. “Millions of Americans are relying on YouTube to resolve this dispute so they can keep watching the news and sports they want — including this week’s Big Game: Texas @ Ohio State.”
Contractual disputes over carriage fees — the money that streaming, cable and satellite TV providers pay for platforms to carry their content — are common between TV networks and carriers like YouTube. Negotiations often go down to the wire and sometimes lead carriers to remove a broadcaster from their lineup if the sides fail to reach agreement. Channels are typically restored once a new carriage deal is struck.
In February, for example, YouTube TV clashed with Paramount Global over the terms of carrying the entertainment and media company’s content (Paramount Skydance owns CBS News.) The companies reached a deal in February.
YouTube TV is the largest streaming provider as measured by total time watched, according to Nielsen.
Dr. Ambreen advises women in their 30s delaying pregnancy to consider an AMH test, a simple blood test revealing ovarian reserve and egg health. This test helps assess future conception chances, especially with family history, irregular periods, or IVF plans.
Are you a woman in your 30s who has decided to delay pregnancy for a few more years? According to health experts, this is the right time to think about your fertility. Dr. Ambreen, an obstetrician-gynaecologist based in Mumbai, with 10 years of experience, has now emphasized taking one important test that can help women understand their chances of conception in the future. Take a look. Take the AMH test
All women who are in their 30s or above, and planning to delay pregnancy, should consider taking the AMH test. “She is 30 years old…she doesn’t want to get pregnant now! Get an AMH test done; plan your options for tomorrow today,” Dr. Ambreen said, in a video shared on Instagram. What is an AMH test The AMH or Anti-Müllerian Hormone test measures the levels of anti-mullerian hormone in a woman’s body. Consider this test a sneak peek at your reproductive health. This test helps to find out the ovarian reserve, also known as the egg pool. It will give an idea of your egg count and health. Don’t be scared by the name; it’s a rather simple blood test, which can tell you how much time is roughly left for you to get a successful pregnancy.
Trump’s Health Mystery DEEPENS: President Hides Massive Bruise From Public Eyes
Should you take this test
The gynaec also explained who should take the test. They include: • Women aged 30 or older: If you are planning to conceive a baby later.• Family history: Early menopause or low ovarian reserve/egg pool.• Irregular periods, ovarian surgery history, chemo/radiation, and endometriosis.• If you are planning to freeze your eggs or conceive through IVF.Here are some things you should know about taking the AMH test. • It is a simple blood test. This test requires no fasting and can be done on any day of the cycle• Prior to the test, report your age, and get an ultrasound (AFC). Don’t base your decision on the number alone.AMH test results
If the test results show lower AMH levels, it means you have fewer eggs and a lower ovarian reserve. According to Dr. Ambreen, in such circumstances, it is best to discuss the options, such as natural conceiving, IVF, or egg freezing, with your doctor immediately. If the test results come back with high AMH levels, it could mean some conditions, such as PCOS. “[If you have PCOS] there may be more eggs, but quality is not guaranteed; there is a lot of risk in this,” the gynaec added. She also debunked some myths surrounding the AMH test and noted that it is not a form of birth control and it does not guarantee a pregnancy. The doctor added that though lifestyle changes such as better sleep, weight management, and quitting smoking may help, it cannot increase the ovarian reserve.Disclaimer: This article is for informational purposes only and should not be considered a substitute for professional diagnosis or treatment. If you are concerned about your fertility options, seek the guidance from a licensed health professional.
New Delhi: While near-term risks to economic activity, principally exports and capital formation remain due to tariff-related uncertainties, the government and the private sector, acting in tandem and concert, can keep the disruptions to a minimum, the Finance Ministry’s ‘Monthly Economic Review’ said on Wednesday. Going ahead, the robust macroeconomic fundamentals continue to bolster the resilience of the Indian economy.
“Setbacks eventually make us stronger and more agile, if handled properly. If the near-term economic pain is absorbed more by those who have the ability and the financial strength to do so, then small and medium enterprises in downstream industries will emerge stronger from the trade imbroglio. Now is the time to demonstrate an understanding of national interest,” according to the ‘Monthly Economic Review July 2025’.
The government’s recent policy initiatives, including the setting up of a Task Force for Next-Generation Reforms and the forthcoming GST reforms, deregulation initiatives of the States, coupled with the sovereign rating upgrade, are set to reduce borrowing costs, attract foreign capital, and bolster investment and consumption.
Add Zee News as a Preferred Source
“These reforms mark the beginning of an accelerated phase of governance transformation, ensuring that India extends its own line of progress, becoming more resilient, inclusive, and globally competitive in an era of rising global economic self-interest,” the Review further stated. The US administration has imposted a hefty 50 per cent tariffs on Indian goods, a move touted as the ‘economic blackmail’.
According to the Economic Review, robust macroeconomic performance and sound fundamentals over the past few years have earned India a well-deserved sovereign rating upgrade by the S&P credit rating agency to ‘BBB’.
“The rating upgrade underscores India’s resilient growth, anchored inflation expectations, and stronger credit metrics, underpinned by fiscal consolidation and improved quality of spending. Building on the growth momentum gained during Q1 of FY26, the Indian economy continues to reflect resilience in July 2025,” it noted.
Record e-way bill generation and a 16-month high in PMI manufacturing point to robust business activity. Further, the stronger expansion in the services PMI indicates growth in the services activity. Domestic demand remained buoyant, as reflected in FMCG sales, UPI transactions, and vehicle sales, supported by strong rural consumption, strengthening urban demand and favourable monsoon conditions.
Forward-looking surveys of the Reserve Bank of India (RBI) signal broad-based improvements in business conditions, with rising capacity utilisation, stable inventories, and optimistic expectations across manufacturing, services, and infrastructure, underscoring sustained confidence in economic activity.
Fiscal performance during Q1 of FY26 reflects a strong capex push, with robust growth in capital expenditure alongside healthy revenue growth driven primarily by non-tax receipts. In July 2025, India’s total exports (goods and services) recorded a growth rate of 4.5 per cent (YoY), driven primarily by a 12.7 per cent growth (YoY) in core merchandise exports.
As of August 08, 2025, the foreign exchange reserves stand at a comfortable level of $695.1 billion, providing an import cover of 11.4 months. “In the dynamic global trade landscape, India has adopted a calibrated approach to negotiating FTAs, aiming to expand market access while protecting domestic interests. Recently, two major agreements, the India-UK CETA and the India-EFTA TEPA, have been concluded, and negotiations continue with a few other nations,” said the Economic Review.
European Commissioner for Trade Maros Sefcovic is expected to visit India next month to assess the progress of free trade agreement (FTA) negotiations with Commerce Minister Piyush Goyal, PTI reported citing an official on Wednesday. The visit is likely to coincide with the conclusion of the 13th round of talks, scheduled from September 8 in New Delhi.The upcoming round is considered crucial as both sides aim to finalise the negotiations by the end of this year. “Quite a bit of movement should be there in this round of talks,” the official said, adding that guidance from ministers may be needed to resolve remaining issues, as some matters may require a political decision.The 12th round of talks concluded in Brussels. India and the 27-nation EU bloc had resumed negotiations in June 2022 for a comprehensive FTA, an investment protection agreement, and a pact on geographical indications (GIs) after a gap of over eight years. Earlier, talks had stalled in 2013 due to differences over the level of market access.On February 28, Prime Minister Narendra Modi and European Commission President Ursula von der Leyen agreed to seal the long-awaited free trade deal by the end of this year.The EU has demanded significant duty cuts in automobiles and medical devices, tax reductions on products including wine, spirits, meat, and poultry, and a strong intellectual property rights framework. Successful conclusion of the pact could make Indian exports such as ready-made garments, pharmaceuticals, steel, petroleum products, and electrical machinery more competitive.The India-EU trade pact negotiations cover 23 policy areas, including Trade in Goods, Trade in Services, Investment, Sanitary and Phytosanitary Measures, Technical Barriers to Trade, Trade Remedies, Rules of Origin, Customs and Trade Facilitation, Competition, Trade Defence, Government Procurement, Dispute Settlement, Intellectual Property Rights, Geographical Indications, and Sustainable Development.India’s bilateral trade in goods with the EU stood at $137.41 billion in 2023-24, with exports worth $75.92 billion and imports at $61.48 billion, making the EU India’s largest trading partner for goods. The EU accounts for about 17% of India’s total exports, while exports from the EU to India make up around 9% of its total overseas shipments.In services, bilateral trade in 2023 was estimated at $51.45 billion, highlighting the growing significance of the EU-India economic partnership.
Meghan Markle clarified her legal name and royal naming protocols during a recent interview, addressing widespread confusion about how British royal titles function.
Speaking to journalist Emily Chang on “The Circuit,” the Duchess of Sussex explained that her legal name is “Meghan, Duchess of Sussex,” while Sussex serves as the family surname she shares with her children.
“When I got married I changed my name but it’s complicated one for people to understand because our last name is not typical in that construct,” Markle said during the interview.
The duchess acknowledged that her American background initially contributed to confusion about British royal conventions.
“What I learned about myself is no matter what my name is or what people call me, I am still the same person,” she added.
Her interview sparked debate on social media, with some users questioning various aspects of royal naming protocols while others mocking the Prince Harry’s wife.
“It’s cute that Meghan and her friend here, both use “Meghan, Duchess of Sussex”, which is the correct formula for a divorced wife. They both missed the (THE) in there. ,” said an X user jokingly.
Another said, “King Charles and parliament can clear up this confusion any moment, if not I am sure Prince William will gladly do it. I think that Crown, Inc should clear this up for this woman.”
One user said, “It’s a Duchy, not a dukedom. And her legal name, according to Letters Patent, is Mountbatten-Windsor.”
Apple, the technology giant, has officially announced the launch date of its new iPhone 17 series. The launch event will be held on September 9 at the Steve Jobs Theater in Cupertino, California, and is being called the “AV Dropping” event.
According to Apple, the iPhone 17 series will include four models: iPhone 17, iPhone 17 Pro, iPhone 17 Pro Max, and an entirely new model, iPhone 17 Air. This new model is expected to attract the most attention due to its ultra-thin design.
All phones in the series will feature A19 and A19 Pro chips, significantly enhancing performance and battery life. Additionally, the Pro models will come with a completely new camera module that allows high-quality photography even in low-light conditions.
Apple has also made significant design changes. The Pro models are being built with a stronger aluminum frame, while the iPhone 17 Air is said to be the lightest and thinnest iPhone ever.
The event will also introduce the Apple Watch Series 11, featuring advanced health-tracking capabilities. In addition, the Apple Watch SE 3 and Rugged Ultra 3 will be launched, offering satellite connectivity for enhanced support in emergency situations.
Significant upgrades are also expected in Apple’s AirPods, including AI features and improved noise cancellation.
Tech experts suggest that Apple may introduce new features aimed at making its products not only smarter but more “human-friendly.” Following this announcement, excitement among consumers and experts is high, with all eyes now on the September 9 event.
